**FORM      10-QSB**

| [X]                            | Quarterly                Report pursuant to Section 13 or 15(d) of the Securities Exchange                Act of                1934 |
|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------|
|                           |                                                                                                                                 |
|                           | For                the quarterly period ended:  **June                30, 2005**                                                |
|                           |                                                                                                                                 |
| [                  ] | Transition                Report pursuant to 13 or 15(d) of the Securities Exchange Act of                1934                       |
|                           |                                                                                                                                 |
|                           | For                the transition period _______ to                __________                                                        |
|                           |                                                                                                                                 |
|                           | Commission                File Number:  **001-14297**                                                                           |

| Nevada                                                                        | 86-0907471                                       |
|-------------------------------------------------------------------------------|--------------------------------------------------|
| (State                or other jurisdiction of incorporation or organization) | (IRS                Employer Identification No.) |

| 301                North Canon Drive, Suite 207, Beverly Hills, California                90210 |
|-------------------------------------------------------------------------------------------------|
| (Address                of principal executive offices)                                         |

| 310-205-9907                                                                                                     |
|------------------------------------------------------------------------------------------------------------------|
| (Issuer’s                telephone number)                                                                 |
|  301                  North Canon Drive, Suite 328, Beverly Hills, California                  90210        |
| (Former                name, former address and former fiscal year, if changed since last                report) |

----

***Table          of Contents***

|                                                   | **TABLE                OF CONTENTS**                                                      |   **Page** |
|--------------------------------------------------------|-----------------------------------------------------------------------------------------------------|----------------------|
| PART                I - FINANCIAL INFORMATION     |
| Item                1:                                 | Financial                Statements                                                            |  3              |
| Item                2:                                 | Management’s                Discussion and Analysis or Plan of                Operation  |  4              |
| Item                3:                                 | Controls                and Procedures                                                         |  7              |
|  PART                II - OTHER INFORMATION  |
| Item                1:                                 | Legal                Proceedings                                                               |  9              |
| Item                2:                                 | Unregistered                Sales of Equity Securities and Use of                Proceeds      |  9              |
| Item                3:                                 | Defaults                Upon Senior Securities                                                 |  10             |
| Item                4:                                 | Submission                of Matters to a Vote of Security                Holders              |  10             |
| Item                5:                                 | Other                Information                                                               |  10             |
| Item                6:                                 | Exhibits                                                                                            |  10        |

----

***Table          of Contents***

**PART      I - FINANCIAL INFORMATION**

**Item      1.** **     Financial      Statements**

| (a)   | Consolidated                Balance Sheet as of June 30, 2005 and December 31,                2004. |
|-----------------|-----------------------------------------------------------------------------------------------------|

| (b)   | Consolidated                Statement of Operations for the three and six month periods ended                June 30,                2005 and 2004, and from inception; |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (c)   | Consolidated                Statement of Cash Flows for the three and six month periods ended                June 30,                2005 and 2004, and from inception; |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (d)   | Notes                to Consolidated Financial                Statements. |
|-----------------|---------------------------------------------------------------------------|

----

***Table          of Contents***

| **DAVI                  SKIN, INC.**                                             |   |   |                                |   |   |                              |   |
|----------------------------------------------------------------------------------|--------|--------|-------------------------------------|--------|--------|-----------------------------------|--------|
| **(formerly                  MW Medical, Inc.)**                                 |   |   |                                |   |   |                              |   |
| **(A                  Developmental Stage Company)**                             |   |   |                                |   |   |                              |   |
|                                                                             |   |   |                                |   |   |                              |   |
| **CONSOLIDATED                  BALANCE SHEET**                                  |   |   |                                |   |   |                              |   |
| **30-Jun-05**                                                                    |   |   |                                |   |   |                              |   |
|                                                                             |   |   |                                |   |   |                              |   |
| **ASSETS**                                                                       |   |   | **As                  Of**          |   |   | **As                  Of**        |   |
|                                                                                  |   |   | **June                  30,**  |   |   | **December                  31,** |   |
| Current                  Assests                                                 |   |   | **2005**                            |   |   | **2004**                          |   |
| Cash                                                                             |   | $      | 128,231                             |   | $      | 506,131                           |   |
| Certificate                  of Deposit                                          |   |   | 2,037,712                           |   |   | 312,952                           |   |
| Prepaid                  Expenses                                                |   |   | -                                   |   |   | 9,375                             |   |
|                                                                             |   |   |                                |   |   |                              |   |
| TOTAL                  CURRENT ASSETS                                            |   | $      | 2,165,943                           |   | $      | 828,458                           |   |
|                                                                             |   |   |                                |   |   |                              |   |
| Fixed                  Assets, net of accumulated depreciation of $9,423         |   |   | 44,489                              |   |   | 35,703                            |   |
|                                                                             |   |   |                                |   |   |                              |   |
| Other                  Assets                                                    |   |   |                                |   |   |                              |   |
| Deposits                                                                         |   |   | 3,700                               |   |   | 3,700                             |   |
|                                                                             |   |   |                                |   |   |                              |   |
| TOTAL                  ASSETS                                                    |   | $      | 2,214,132                           |   | $      | 867,861                           |   |
|                                                                             |   |   |                                |   |   |                              |   |
| LIABILITIES                  AND STOCKHOLDERS' EQUITY                            |   |   |                                |   |   |                              |   |
|                                                                             |   |   |                                |   |   |                              |   |
| Current                  Liabilities                                             |   |   |                                |   |   |                              |   |
| Accounts                  payable                                                |   |   | 71,330                              |   |   | 39,160                            |   |
| Notes                  payable- related parties                                  |   |   | 220,000                             |   |   | 210,000                           |   |
| Funds                  received pending stock issuances                          |   |   | 105,500                             |   |   | 10,500                            |   |
|                                                                             |   |   |                                |   |   |                              |   |
| TOTAL                  CURRENT LIABILITIES                                       |   | $      | 396,830                             |   | $      | 259,660                           |   |
|                                                                             |   |   |                                |   |   |                              |   |
| Stockholders'                  Equity                                            |   |   |                                |   |   |                              |   |
| Preferred                  stock; $.001 par value; 10,000,000 shares authorized, |   |   |                                |   |   |                              |   |
| and                  no shares issued and outstanding                            |   |   | -                                   |   |   | -                                 |   |
| Common                  stock; $.001 par value; 90,000,000 shares authorized,    |   |   |                                |   |   |                              |   |
| 11,477,453                  shares issued and outstanding                        |   |   | 11,477                              |   |   | 10,713                            |   |
| Additional                  paid-in capital                                      |   |   | 6,014,303                           |   |   | 4,241,339                         |   |
| Accumulated                  deficit during developmental stage                  |   |   | (4,201,978                          | )      |   | (3,635,651                        | )      |
| Stock                  subscriptions receivable                                  |   |   | (6,500                              | )      |   | (8,200                            | )      |
|                                                                             |   |   |                                |   |   |                              |   |
| TOTAL                  STOCKHOLDERS' EQUITY                                      |   | $      | 1,817,302                           |   | $      | 608,201                           |   |
|                                                                             |   |   |                                |   |   |                              |   |
| TOTAL                  LIABILITIES AND STOCKHOLDERS' EQUITY                      |   | $      | 2,214,132                           |   | $      | 867,861                           |   |

----

***Table          of Contents***

| **DAVI                  SKIN, INC.**                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
|-------------------------------------------------------------------|--------|--------|--------------------------------------------------------------|---------|--------|------------------------------------------------|--------|--------|-----------------------------------------------|---------|--------|-----------|--------|--------|---------------------------------------------|--------|
| **(formerly                  MW Medical, Inc.)**                  |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| **(A                  Developmental Stage Company)**              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| **CONSOLIDATED                  STATEMENT OF OPERATIONS**         |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
|                                                                   |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   | **From                  the Date of**  |   |
|                                                              |   |   | **Three                  months ended June 30th**  |    |   | **Six                  months ended June 30,** |   |   | **inception                  March 21, 2004** |    |
|                                                              |   |   | **2005**                                                     |    |   | **2004**                                       |   |   | **2005**                                      |    |   | **2004**  |   |   | **through                  June 30, 2005**  |   |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Revenues                                                          |   |   | -                                                            |    |   | -                                              |   |   | -                                             |    |   | -         |   |   | -                                           |   |
| Cost                  of revenues                                 |   |   | -                                                            |    |   | -                                              |   |   | -                                             |    |   | -         |   |   | -                                           |   |
| Gross                  Profit (Loss)                              |   |   | -                                                            |    |   | -                                              |   |   | -                                             |    |   | -         |   |   | -                                           |   |
| Operating                  Expenses                               |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Selling,                  general and administrative              |   |   | 151,688                                                      |    |   | 175,756                                        |   |   | 282,370                                       |    |   | 175,756   |   |   | 1,107,626                                   |   |
| Depreciation                                                      |   |   | 3,360                                                        |    |   | 999                                            |   |   | 6,015                                         |    |   | 999       |   |   | 9,424                                       |   |
| Consulting                  Fees                                  |   |   | 65,708                                                       |    |   |                                           |   |   | 204,186                                       |    |   |      |   |   | 2,462,189                                   |   |
| Professional                  Fees                                |   |   | 27,351                                                       |    |   |                                           |   |   | 74,077                                        |    |   |      |   |   | 618,258                                     |   |
| Total                  oper. Expenses                             |   |   | 248,107                                                      |    |   | 176,755                                        |   |   | 566,648                                       |    |   | 176,755   |   |   | 4,197,497                                   |   |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| (Loss)                  From operations                           |   |   | (248,107                                                     | )       |   | (176,755                                       | )      |   | (566,648                                      | )       |   | (176,755  | )      |   | (4,197,497                                  | )      |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Other                  Income (expenses)                          |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Interest                  expenses                                |   |   | (5,005                                                       | )       |   | -                                              |   |   | (10,005                                       | )       |   | -         |   |   | (20,005                                     | )      |
| Interest                  income                                  |   |   | 8,850                                                        |    |   | 874                                            |   |   | 10,326                                        |    |   | 874       |   |   | 15,524                                      |   |
|                                                              |   |   | 3,845                                                        |    |   | 874                                            |   |   | 321                                           |    |   | 874       |   |   | (4,481                                      | )      |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| NET                  (LOSS)                                       |   |   | (244,262                                                     | )       |   | (175,881                                       | )      |   | (566,327                                      | )       |   | (175,881  | )      |   | (4,201,978                                  | )      |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Basic                  (loss) per common share                    |   |   | (0.02                                                        | )  |   | (0.02                                          | )      |   | (0.05                                         | )  |   | (0.02     | )      |   |                                        |   |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Diluted                  loss per common share                    |   |   | (0.02                                                        | )       |   | (0.02                                          | )      |   | (0.05                                         | )       |   | (0.02     | )      |   |                                        |   |
|                                                              |   |   |                                                         |    |   |                                           |   |   |                                          |    |   |      |   |   |                                        |   |
| Basic                  Weighted average common shares outstanding |   |   | 11,303,392                                                   |    |   | 9,606,527                                      |   |   | 10,969,483                                    |    |   | 9,606,527 |   |   |                                        |   |

----

***Table          of Contents***

| **DAVI                  SKIN, INC.**                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
|------------------------------------------------------------------|--------|-----------------------------------------------|--------|--------|-------------------------------------------|--------|--------|------------------------------------------|--------|--------|-----------------------------------------------|--------|
| **(formerly                  MW Medical, Inc.)**                 |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| **(A                  Developmental Stage Company)**             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| **CONSOLIDATED                  STATEMENT OF CASH FLOWS**        |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
|                                                             |   | **For                  the period**      |   |   | **For                  the period**       |   |   | **For                  the period**      |   |   |                                          |   |
|                                                             |   | **from                  April 1, 2005**  |   |   | **from                  January 1, 2005** |   |   | **from                  March 21, 2004** |   |   | **From                  the Date of**         |   |
|                                                             |   | **through                  June 30,**    |   |   | **through                  June 30,**     |   |   | **through                  June 30,**    |   |   | **inception                  March 21, 2004** |   |
|                                                             |   | **2005**                                      |   |   | **2005**                                  |   |   | **2004**                                 |   |   | **through                  June 30, 2005**    |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| **OPERATING                  ACTIVITIES**                        |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Net                  (loss)                                      | $      | (244,262                                      | )      |   | (566,327                                  | )      |   | (175,881                                 | )      |   | (4,201,978                                    | )      |
| Adjustments                  to reconcile net (loss) to net      |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| cash                  used in operating activities:              |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Stock                  based compensation & expenses         |   | 19,636                                        |   |   | 19,636                                    |   |   | 2,567                                    |   |   | 3,009,940                                     |   |
| Depreciation                  and amortization                   |   | 3,360                                         |   |   | 6,015                                     |   |   | 999                                      |   |   | 9,424                                         |   |
| Accrued                  interest                                |   | 5,000                                         |   |   | 10,000                                    |   |   |                                     |   |   | 20,000                                        |   |
| Changes                  in operating assets and liabilities:    |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Change                  in accounts payable and accrued expenses |   | -                                             |   |   | -                                         |   |   | 17,889                                   |   |   | -                                             |   |
| Certificate                  of Deposit                          |   | (1,883,850                                    | )      |   | (1,724,760                                | )      |   |                                     |   |   | (2,037,712                                    | )      |
| Prepaid                  Expenses                                |   | -                                             |   |   | 9,375                                     |   |   |                                     |   |   | -                                             |   |
| Deposits                                                         |   | -                                             |   |   | -                                         |   |   |                                     |   |   | (3,700                                        | )      |
| Accounts                  payable                                |   | (2,603                                        | )      |   | 21,669                                    |   |   |                                     |   |   | 60,829                                        |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Short                  term notes payable                        |   | -                                             |   |   | -                                         |   |   |                                     |   |   | 10,500                                        |   |
| Notes                  payable- related party                    |   | -                                             |   |   | -                                         |   |   |                                     |   |   | 200,000                                       |   |
| Net                  Cash (used) by                              |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Operating                  Activities                            |   | (2,102,719                                    | )      |   | (2,224,392                                | )      |   | (154,426                                 | )      |   | (2,932,697                                    | )      |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| **INVESTING                  ACTIVITIES**                        |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Cash                  flow from investing activities:            |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Cash                  outlay for certificate of deposit          |   | -                                             |   |   | -                                         |   |   | (500,874                                 | )      |   | -                                             |   |
| Purchase                  of fixed assets                        |   | (14,800                                       | )      |   | (14,800                                   | )      |   | (20,751                                  | )      |   | (53,912                                       | )      |
| Net                  cash used in investing activities           |   | (14,800                                       | )      |   | (14,800                                   | )      |   | (521,625                                 | )      |   | (53,912                                       | )      |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| **FINANCING                  ACTIVITIES**                        |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Cash                  flows from financing activities            |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Proceeds                  from stock transactions                |   | 324,000                                       |   |   | 1,861,292                                 |   |   | 765,348                                  |   |   | 3,114,840                                     |   |
| Net                  cash provided by                            |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Financing                  Activities                            |   | 324,000                                       |   |   | 1,861,292                                 |   |   | 765,348                                  |   |   | 3,114,840                                     |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Net                  change in cash and cash equivalents         |   | (1,793,519                                    | )      |   | (377,900                                  | )      |   | 89,297                                   |   |   | 128,231                                       |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Cash                  beginning of period                        |   | 1,921,750                                     |   |   | 506,131                                   |   |   | -                                        |   |   | -                                             |   |
|                                                             |   |                                          |   |   |                                      |   |   |                                     |   |   |                                          |   |
| Cash                  end of period                              | $      | 128,231                                       |   | $      | 128,231                                   |   | $      | 89,297                                   |   | $      | 128,231                                       |   |

----

***Table          of Contents***

| **DAVI                  SKIN, INC.**                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
|--------------------------------------------------------------------------|------------------------------------------|-----------------------------------|--------|-----------------------------------------|------------|--------|------------------------------|----------------|--------|------------------------------------|------------|--------|------------------|----------------|--------|--------|---------------|--------|--------|-----------------------|--------|--------|---------------|--------|
| **(formerly                  MW Medical, Inc.)**                         |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| **(A                  Developmental Stage Company)**                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| **CONSOLIDATED                  STATEMENT OF STOCKHOLDERS EQUITY**       |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |
| **FOR                  THE PERIOD FROM MARCH 24, 2004 TO JUNE 30, 2005** |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   | **Accumulated**  |   |   |          |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   | **Deficit**           |   |   | **Total**     |   |
| **2004                    Stock Transactions**                           |  **Preferred                Stock** | **Common                  Stock** |   | **Addl.                  Subscription** |       |   | **Paid                  In** |           |   | **During                  devel.** |       |   | **Stockholders** |           |
|                                                                     |                                     | **Shares**                   |   |                                    | **Amount** |   |                         | **Shares**     |   |                               | **Amount** |   |             | **Receivable** |   |   | **Capital**   |   |   | **Stage**             |   |   | **Equity**    |   |
| Balance,                  3/21/04                                        |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| (Date                  of Inception)                                     |                                     | -                                 |   | $                                       | -          |   |                         | -              |   | $                                  | -          |   | $                | -              |   |   | -             |   |   | -                     |   |   | -             |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| 2004                  Issuances                                          |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| stock                  to founders,                                      |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| $.001                  per share                                         |                                     | -                                 |   | $                                       | -          |   |                         | 8,200,000      |   | $                                  | 8,200      |   |             |           |   |   | -             |   |   | -                     |   |   | 8,200         |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             | (8,200         | )      |   |          |   |   |                  |   |   | (8,200        | )      |
| Issuances                  of common                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| stock,                  weighted                                         |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| average                  price of $.50                                   |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| per                  share                                               |                                     | -                                 |   | $                                       | -          |   |                         | 1,545,634      |   | $                                  | 1,546      |   | $                | -              |   |   | 763,802       |   |   | -                     |   |   | 765,348       |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| Issuance                  of common                                      |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| stock                  related to                                        |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| acquisition                  of                                          |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| MW                  Medical, Inc.                                        |                                     | -                                 |   | $                                       | -          |   |                         | 667,726        |   | $                                  | 667        |   | $                | -              |   |   | (198,078      | )      |   | -                     |   |   | (197,411      | )      |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| Issuance                  of common                                      |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| stock                  related to                                        |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| consulting                  services                                     |                                     | -                                 |   | $                                       | -          |   |                         | 300,000        |   | $                                  | 300        |   | $                | -              |   |   | 3,675,615     |   |   | -                     |   |   | 3,675,915     |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| Net                  loss                                                |                                     | -                                 |   | $                                       | -          |   |                         | -              |   | $                                  | -          |   | $                | -              |   |   | -             |   |   | (3,635,651            | )      |   | (3,635,651    | )      |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| **Balance,                  December 31, 2004**                          |                                     | **0**                             |   |                                    | **0**      |   |                         | **10,713,360** |   |                               | **10,713** |   | **$**            | **(8,200**     | **)**  | **$**  | **4,241,339** |   | **$**  | **(3,635,651**        | **)**  | **$**  | **608,201**   |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| **2005                  Stock transactions**                             |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| Issuances                  of common                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| stock,                  weighted                                         |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| average                  price of $.50                                   |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| per                  share                                               |                                     | -                                 |   | $                                       | -          |   |                         | 764,093        |   | $                                  | 764        |   | $                | 1,700          |   |   | 224,751       |   |   |                  |   |   | 227,215       |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| Issuance                  of common                                      |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| stock                  related to                                        |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| consulting                  services                                     |                                     | -                                 |   | $                                       | -          |   |                         | -              |   | $                                  | -          |   | $                | -              |   |   | 1,548,213     |   |   | -                     |   |   | 1,548,213     |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| Net                  loss                                                |                                     | -                                 |   | $                                       | -          |   |                         | -              |   | $                                  | -          |   | $                | -              |   |   | -             |   |   | (566,327              | )      |   | (566,327      | )      |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| **2005                  Stock issuances**                                |                                     | **-**                             |   |                                    | **-**      |   |                         | **764,093**    |   |                               | **764**    |   |             | **1,700**      |   |   | **1,772,964** |   |   | **(566,327**          | **)**  |   | **1,209,101** |   |
|                                                                     |                                     |                              |   |                                    |       |   |                         |           |   |                               |       |   |             |           |   |   |          |   |   |                  |   |   |          |   |
| **Balance                  June 30, 2005**                               |                                     | **-**                             |   |                                    | **-**      |   |                         | **11,477,453** |   |                               | **11,477** |   |             | **(6,500**     | **)**  |   | **6,014,303** |   |   | **(4,201,978**        | **)**  |   | **1,817,302** |   |

----

***Table          of Contents***

**DAVISKIN,        INC.**

**(formerly        MW Medical, Inc.)**

**(A        Development State Company)**

**NOTES        TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)**

| **1.** | **BASIS                  OF PRESENTATION** |
|--------|--------------------------------------------|

| **2.** | **DESCRIPTION                  OF BUSINESS, HISTORY AND SUMMARY OF SIGNIFICANT                  POLICIES** |
|--------|------------------------------------------------------------------------------------------------------------|

----

***Table            of Contents***

**DAVISKIN,        INC.**

**(formerly        MW Medical, Inc.)**

**(A        Development State Company)**

**NOTES        TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)**

**(continued)**

----

***Table            of Contents***

**DAVISKIN,        INC.**

**(formerly        MW Medical, Inc.)**

**(A        Development State Company)**

**NOTES        TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)**

**(continued)**

----

***Table            of Contents***

**DAVISKIN,        INC.**

**(formerly        MW Medical, Inc.)**

**(A        Development State Company)**

**NOTES        TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)**

**(continued)**

----

***Table          of Contents***

**Item      2.     Management’s Discussion and      Analysis or Plan of Operation**

**Forward-Looking      Statements**

**Plan      of Operation**

| 1.   | Cleanser; |
|----------------|-----------|

| 2.   | Facial                Scrub; |
|----------------|------------------------------|

| 3.   | Eye                Cream; |
|----------------|---------------------------|

| 4.   | Revitalizing                Moisturizer; |
|----------------|------------------------------------------|

| 5.   | Daily                Moisturizer with an SPF rating for sun protection; |
|----------------|-------------------------------------------------------------------------|

| 6.   | Intensive                treatment serum; |
|----------------|-------------------------------------------|

| 7.   | Purifying                Clay Mask; |
|----------------|-------------------------------------|

| 8.   | Toner;                and |
|----------------|---------------------------|

| 9.   | Lip                Treatment |
|----------------|------------------------------|

----

***Table          of Contents***

| a.   | the                shape and size of the product                containers; |
|----------------|-----------------------------------------------------------------------------|

| b.   | the                types of caps; |
|----------------|-----------------------------------|

| c.   | the                packaging; |
|----------------|-------------------------------|

| d.   | the                logo and label designs; and |
|----------------|------------------------------------------------|

| e.   | unit                cartons. |
|----------------|------------------------------|

----

***Table          of Contents***

| Robert                  G. Mondavi  | Founder/Chairman                  of Robert Mondavi Winery                                              |
|-------------------------------------|---------------------------------------------------------------------------------------------------------|
| Timothy                  J. Mondavi | Vice                  Chairman of Robert Mondavi Winery                                                 |
| R.                  Michael Mondavi | Former** **President                  and CEO of Robert Mondavi Winery                             |
| Michael                  Johnson    | Olympic                  Gold Medalist and World Record Holder                                          |
| Jean-Marc                  Benet    | General                  Manager for Darphin USA, owned by Estee Lauder                                 |
| Joseph                  Spellman    | President                  of Mac Cosmetics and Senior Advisor to Estee Lauder                  Company |

**Assets**

**Liabilities      and Stockholders Equity**

----

***Table          of Contents***

**Liquidity      and Capital Resources**

**Off      Balance Sheet Arrangements**

**Going      Concern**

**Revenue      Recognition**

**Item      3.     Controls and Procedures**

----

***Table          of Contents***

----

***Table          of Contents***

**PART      II - OTHER INFORMATION**

**Item      1.     Legal      Proceedings**

**Item      2.     Unregistered Sales of Equity      Securities and Use of Proceeds**

----

***Table          of Contents***

**Item      3.     Defaults upon Senior      Securities**

**Item      4.     Submission of Matters to a Vote      of Security Holders**

**Item      5.     Other      Information**

**Item      6.      Exhibits**

| **Exhibit                Number** | **Description                of Exhibit**                                                                                                                                                                                                                |
|-----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1                              | Certification                of Chief Executive Officer pursuant to                18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the                Sarbanes-Oxley Act of 2002                                                           |
| 31.2                              | Certification                of Chief Financial Officer pursuant to                18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the                Sarbanes-Oxley Act of 2002                                                           |
| 32.1                              | Certification                of Chief Executive Officer and Chief                Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted                pursuant                to Section 906 of the Sarbanes-Oxley Act of                2002 |

----

***Table          of Contents***

**SIGNATURES**

|   | **DAVI                SKIN, INC.**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Date:  | August                20, 2005                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|   |   By:/s/                  Parrish                Medley                                                                                         Parrish MedleyTitle:                   **Chief                Executive Officer**  |

----